<a href="https://www.fiercebiotech.com/medtech/predicta-links-spanish-university-offer-diagnostic-blood-cancers" hreflang="en">Predicta links with Spanish university to offer diagnostic for blood cancers</a>
Predicta Biosciences has partnered with the Clínica Universidad de Navarra’s CIMA Lab Diagnostics to launch a new assay for diagnosing blood cancers, combining Predicta's GenoPredicta assay with advanced flow cytometry technology. This collaboration aims to enhance the detection and monitoring of blood cancers in Spain and other EU countries.
Predicta Biosciences' collaboration with the Clínica Universidad de Navarra’s CIMA Lab Diagnostics to develop the GenoPredicta assay for blood cancers is a significant step in precision oncology, leveraging flow cytometry to enhance diagnostic capabilities. This partnership could be a potential investment opportunity or a partnership model for other companies focused on integrating advanced diagnostic technologies in the European market.